GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MyoKardia Inc (NAS:MYOK) » Definitions » Interest and Commission Paid

MyoKardia (MyoKardia) Interest and Commission Paid


View and export this data going back to 2015. Start your Free Trial

What is MyoKardia Interest and Commission Paid?

Interest and Commission Paid only applicable to companies reporting Cash Flow from Operations in direct method.


MyoKardia (MyoKardia) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1000 Sierra Point Parkway, Brisbane, CA, USA, 94005
MyoKardia Inc is a US-based clinical-stage biopharmaceutical company which is engaged in discovering, developing and commercializing targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. The company mainly focuses on the treatment of heritable cardiomyopathies and genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. It uses its medicine platform to generate an initial pipeline of therapeutic programs for the chronic treatment of the two most common forms of heritable cardiomyopathy-hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy. The company's products include MYK-461 s an orally administered small molecule to reduce excessive cardiac muscle contractility leading to HCM.
Executives
Anastasios Gianakakos director, officer: President and CEO 333 ALLERTON AVE., SOUTH SAN FRANCISCO CA 94080
Denelle J Waynick officer: General Counsel C/O MYOKARDIA, INC. 1000 SIERRA POINT PARKWAY BRISBANE CA 94005
Mary B Cranston director C/O VISA INC., P.O. BOX 8999, SAN FRANCISCO CA 94128-8999
Mark L Perry director 176 WEST BLITHEDALE AVE, MILL VALLEY CA 94941
David P Meeker director C/O PENWEST PHARMACEUTICALS CO, 39 OLD RIDGEBURY ROAD SUITE 11, DANBURY CT 06810
Wendy L Yarno director
Sunil Agarwal director 60 LEVERONI COURT, NOVATO CA 94949
Kimberly J Popovits director 301 PENOBSCOT DRIVE, REDWOOD CITY CA 94063
Jake Bauer officer: Chief Business Officer C/O MYOKARDIA, INC., 333 ALLERTON AVENUE, SOUTH SAN FRANCISCO CA 94080
Taylor C. Harris officer: Chief Financial Officer 6035 STONERIDGE DRIVE, PLEASANTON CA 94588
William Fairey officer: See Remarks C/O CHEMOCENTRYX, INC., 850 MAUDE AVE., MOUNTAIN VIEW CA 94043
Cynthia J Ladd officer: General Counsel C/O AGY THERAPEUTICS INC, 290 UTAH AVE, SOUTH SAN FRANCISCO CA 94080
Robert Scott Mcdowell officer: Chief Scientific Officer C/O MYOKARDIA, INC., 333 ALLERTON AVE., SOUTH SAN FRANCISCO CA 94080
June Lee officer: EVP, Chief Development Officer C/O MYOKARDIA, INC., 333 ALLERTON AVE, SOUTH SAN FRANCISCO CA 94080
Anofi 10 percent owner 46 AVENUE DE LA GRANDE ARMEE, PARIS I0 75017